• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Exclusive

An hour in the Oval Office with President Trump Fortune Editor-in-Chief: Alyson Shontell sat down with President Trump in the Oval Office for an hour. Tariffs, Intel, AI, Boeing, Iran—and the question every CEO eventually has to answer: who's next?

An hour in the Oval Office with President Trump Fortune Editor-in-Chief: Alyson Shontell sat down with President Trump in the Oval Office for an hour. Tariffs, Intel, AI, Boeing, Iran—and the question every CEO eventually has to answer: who's next?

An hour in the Oval Office with President Trump Fortune Editor-in-Chief: Alyson Shontell sat down with President Trump in the Oval Office for an hour. Tariffs, Intel, AI, Boeing, Iran—and the question every CEO eventually has to answer: who's next?

An hour in the Oval Office with President Trump Fortune Editor-in-Chief: Alyson Shontell sat down with President Trump in the Oval Office for an hour. Tariffs, Intel, AI, Boeing, Iran—and the question every CEO eventually has to answer: who's next?

An hour in the Oval Office with President Trump Fortune Editor-in-Chief: Alyson Shontell sat down with President Trump in the Oval Office for an hour. Tariffs, Intel, AI, Boeing, Iran—and the question every CEO eventually has to answer: who's next?

An hour in the Oval Office with President Trump Fortune Editor-in-Chief: Alyson Shontell sat down with President Trump in the Oval Office for an hour. Tariffs, Intel, AI, Boeing, Iran—and the question every CEO eventually has to answer: who's next?

An hour in the Oval Office with President Trump Fortune Editor-in-Chief: Alyson Shontell sat down with President Trump in the Oval Office for an hour. Tariffs, Intel, AI, Boeing, Iran—and the question every CEO eventually has to answer: who's next?

An hour in the Oval Office with President Trump Fortune Editor-in-Chief: Alyson Shontell sat down with President Trump in the Oval Office for an hour. Tariffs, Intel, AI, Boeing, Iran—and the question every CEO eventually has to answer: who's next?

An hour in the Oval Office with President Trump Fortune Editor-in-Chief: Alyson Shontell sat down with President Trump in the Oval Office for an hour. Tariffs, Intel, AI, Boeing, Iran—and the question every CEO eventually has to answer: who's next?

An hour in the Oval Office with President Trump Fortune Editor-in-Chief: Alyson Shontell sat down with President Trump in the Oval Office for an hour. Tariffs, Intel, AI, Boeing, Iran—and the question every CEO eventually has to answer: who's next?

HealthBrainstorm Health

Brainstorm Health: After the Flood

By
Clifton Leaf
Clifton Leaf
and
Laura Entis
Laura Entis
Down Arrow Button Icon
By
Clifton Leaf
Clifton Leaf
and
Laura Entis
Laura Entis
Down Arrow Button Icon
September 5, 2017, 1:10 PM ET

Good morning, readers. This is Laura (filling in for Cliff).

Hope you had a great holiday weekend. Unfortunately, with the return of the work week comes news of another hurricane: Irma, which has strengthened into a Category 5 storm, appears to be headed for the Caribbean and Florida.

In the meantime, Houston is starting the long recovery process in the wake of Hurricane Harvey, which has claimed the lives of dozens. In the short-term, this includes assessing and clearing the damage.

In the longer-term, it means much more: rebuilding, yes, but also addressing the physical and psychological wounds that can fester long after the water recedes.

Here’s what past storms have taught us. Houston residents can expect an increase in infections (exacerbated by flood waters that merged with sewage and dredged up other toxic debris), and the spread of contagious diseases (aided by crowded conditions in shelters) in the coming weeks. After Katrina, the CDC reported a host of infectious outbreaks among evacuees, including 30 documented cases of MRSA, an infection caused by a type of antibiotic-resistant staph bacteria. As a precautionary measure, Houston residents are advised to stay out of the water get tetanus booster shots.

Complications from chronic conditions including cardiovascular disease, respiratory illness, and diabetes are also expected to increase post-flood, a danger compounded by the fact that access to medication remains an issue. Past floods indicate that the overall mortality rates will remain elevated for months to come.

And then there’s the emotional toil. Research involving Katrina victims suggests that in the wake of the storm, the city will see a rise in mental health diagnosis. Unlike a surface wound that, when properly cared for, heals within a set time period, emotional scars don’t come with a contained path to recovery. They can linger for months, even years, and flare up again long after the initial, triggering episode.

Studies on residents in regions affected by Katrina, for example, found that the prevalence of PTSD was up 21% a year after the hurricane, while the percentage of those who said they experienced suicidal thoughts climbed from 2.8% to 6.4%. These numbers provide a glimpse at the long road ahead for Harvey victims, many of whom have lost their homes, some of whom have lost loved ones.

As the flood waters recede and the world moves on to the track the next hurricane, Houston (as is true for New Orleans, New York, Hawaii, and so many other cities and regions) will feel the effects of Harvey for years to come.

DIGITAL HEALTH

The robots are coming. We know automation will eventually render many jobs obsolete. That said, some professions are safer than others (those in manufacturing should be worried, while hair stylists can breathe a sigh of relief). This dichotomy extends to the medical industry, where “high touch” jobs (such as physicians, nurses, and physical therapists) are relatively safe from being replaced by a machine. Radiologists, who enjoy a cushy, average annual salary of $400,000, don’t fit inside this category -- and that has them worried. (NPR)

INDICATIONS

FDA shuts down CAR-T clinical trials. A mere days after the FDA approved CAR T-cell immunotherapy, which targets cancer cells by harnessing the body’s own immune system, it shut down two clinical trials involving the treatment following the death of a patient. Both trials were being conducted by Cellectis for its off-the-shelf version of CAR-T therapy. (Endpoints)

THE BIG PICTURE

Getting specific about cancer treatment. Writing for The New Yorker, Siddhartha Mukherjee takes an in-depth look at why it’s still so hard to predict whether a patient’s cancer will become metastatic or not (and, as a result, to determine the best method of treatment). The way forward could involve a radically different approach to cancer treatment, one based on the host’s peculiarities as well as characteristics of the cancer itself. (The New Yorker)

Trump to nominate a ‘drug czar’. His choice to head the Office of National Drug Control Policy? Long-time supporter Rep. Tom Marino, who originally withdrew his name for consideration citing his mother’s critical illness. Now Marino, who sits on a bipartisan congressional committee focused on creating laws to fight the opioid crisis, has apparently withdrawn his withdrawal. (STAT News)

Birth control belly. I’ve heard it repeated countless times, from friends and doctors alike: the pill causes weight gain. Except it’s not true. Or, at the very least, it’s complicated. While taking the pill can, in specific instances, lead to weight gain, the relationship is thornier than a simple cause-and-effect. (New York Magazine)

REQUIRED READING

Employers Can’t Take Away Privacy Rights, European Court Rules, by David Meyer

Green Giant Has a New Plan to Get You to Eat Your (Frozen) Veggies, by Beth Kowitt

Sean Spicer Has a New Job,  by Claire Zillman

CEOs From More Than 400 Leading U.S. Companies Urge Trump to Keep DACA, by Joseph Hincks

Can Flying Taxis Work? Tencent Invests in German Aviation Startup Lilium To Find Out, by David Meyer

About the Authors
By Clifton Leaf
See full bioRight Arrow Button Icon
By Laura Entis
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

david hassell
Future of WorkFortune Workplace Innovation
CEO of AI-powered performance review firm says annual evaluations weren’t designed for the AI era: ‘The practice just hasn’t kept up’
By Jake AngeloMay 19, 2026
6 hours ago
Employers are quietly pausing 401(k) matches again. The last time this happened was the 2008 recession and Covid
Personal Finance401(k)
Employers are quietly pausing 401(k) matches again. The last time this happened was the 2008 recession and Covid
By Courtney Vinopal and HR BrewMay 18, 2026
1 day ago
CDC to escalate Ebola response after WHO declares emergency
HealthHealth
CDC to escalate Ebola response after WHO declares emergency
By Jessica Nix and BloombergMay 17, 2026
2 days ago
WHO declares latest Ebola outbreak a global health emergency. A rare variant of the disease with no approved treatments is to blame
HealthHealth
WHO declares latest Ebola outbreak a global health emergency. A rare variant of the disease with no approved treatments is to blame
By Chinedu Asadu and The Associated PressMay 17, 2026
2 days ago
hoeg
HealthFDA
RFK ally confirms she was fired by FDA: ‘I learned so much and leave with no regrets’
By Matthew Perrone and The Associated PressMay 16, 2026
3 days ago
lawyer
CommentaryLaw
Would you hire the lawyer who just got sanctioned for using AI?
By Alexandra SmythMay 16, 2026
4 days ago

Most Popular

The Bezos family just donated $100 million to help achieve one of Mayor Zohran Mamdani’s top campaign promises
Politics
The Bezos family just donated $100 million to help achieve one of Mayor Zohran Mamdani’s top campaign promises
By Jake AngeloMay 12, 2026
7 days ago
While Trump insisted the Iran war would end ‘soon,’ an account in his name was buying millions in oil, defense, and gold
Economy
While Trump insisted the Iran war would end ‘soon,’ an account in his name was buying millions in oil, defense, and gold
By Eva RoytburgMay 18, 2026
1 day ago
EXCLUSIVE: An hour in the Oval Office with the CEO-in-Chief, President Trump
Politics
EXCLUSIVE: An hour in the Oval Office with the CEO-in-Chief, President Trump
By Alyson ShontellMay 18, 2026
2 days ago
Current price of silver as of Monday, May 18, 2026
Personal Finance
Current price of silver as of Monday, May 18, 2026
By Joseph HostetlerMay 18, 2026
2 days ago
Current price of oil as of May 18, 2026
Personal Finance
Current price of oil as of May 18, 2026
By Joseph HostetlerMay 18, 2026
1 day ago
Employers are quietly pausing 401(k) matches again. The last time this happened was the 2008 recession and Covid
Personal Finance
Employers are quietly pausing 401(k) matches again. The last time this happened was the 2008 recession and Covid
By Courtney Vinopal and HR BrewMay 18, 2026
1 day ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.